Loading the player...


INFO:
The antibody-drug conjugate trastuzumab deruxtecan (Enhertu) lengthens life for patients with HER2-low metastatic breast cancer. Learn more.
Trastuzumab Deruxtecan Effective for HER2-Low Breast Cancer